These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29975926)

  • 1. Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway.
    Hou T; Zhou L; Wang L; Kazobinka G; Chen Y; Zhang X; Chen Z
    Cell Physiol Biochem; 2018; 47(6):2250-2260. PubMed ID: 29975926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.
    Sahu SN; Nunez S; Bai G; Gupta A
    Am J Physiol Cell Physiol; 2007 Jun; 292(6):C2288-96. PubMed ID: 17329398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway.
    Xiao S; Chen J; Wei Y; Song W
    Eur J Med Res; 2024 May; 29(1):302. PubMed ID: 38811952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon.
    Dierks S; von Hardenberg S; Schmidt T; Bremmer F; Burfeind P; Kaulfuß S
    Oncotarget; 2015 May; 6(15):13591-606. PubMed ID: 26079947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanisms of leupaxin involved in prostate carcinoma metastasis].
    Zhu GH; Dai HP; Shen Q
    Zhonghua Nan Ke Xue; 2013 Jun; 19(6):555-8. PubMed ID: 23862238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    Lv S; Wang W; Wang H; Zhu Y; Lei C
    BMC Cancer; 2019 Mar; 19(1):204. PubMed ID: 30845932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
    Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.
    Lu JJ; Su YW; Wang CJ; Li DF; Zhou L
    Tumori; 2019 Jun; 105(3):231-242. PubMed ID: 30674231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.
    Sun CH; Chang YH; Pan CC
    Histopathology; 2011 Jun; 58(7):1054-63. PubMed ID: 21707707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leupaxin is similar to paxillin in focal adhesion targeting and tyrosine phosphorylation but has distinct roles in cell adhesion and spreading.
    Chen PW; Kroog GS
    Cell Adh Migr; 2010; 4(4):527-40. PubMed ID: 20543562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
    J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.
    Zhuang X; Lv M; Zhong Z; Zhang L; Jiang R; Chen J
    J Exp Clin Cancer Res; 2016 Aug; 35(1):130. PubMed ID: 27576342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.
    Wang W; Jiang X; Xia F; Chen X; Li G; Liu L; Xu Q; Zhu M; Chen C
    Mol Biol Rep; 2023 Jan; 50(1):453-464. PubMed ID: 36348197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway.
    Wang J; Ma W; Liu Y
    Cancer Biomark; 2017 Dec; 20(4):425-434. PubMed ID: 28946549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.